Full access to medicines is hampered by a variety of factors. Two important barriers are high prices and regulatory issues such as long lag times in bringing medicines to the market.
@DrTedros @WHOAFRO @WHOKenya @MOH_Kenya
#UHC
https://www.who.int/medicines/news/2019/WHO-MoU-signed-with-int-generic-biosimilar/en/ …
5:56 AM - 22 Oct 2019
0 replies
3 retweets
8 likes
Loading seems to be taking a while.
Twitter may be over capacity or experiencing a momentary hiccup. Try again or visit Twitter Status for more information.